title: Acute cytomegalovirus infection as a transient risk factor for thrombosis: report of three cases and focus on specific coagulation pathways.
authors.forename: Marie
authors.initials: M
authors.lastname: Pichenot
authors.forename: Sandrine
authors.initials: S
authors.lastname: Morell-Dubois
authors.forename: Clara
authors.initials: C
authors.lastname: Flateau
authors.forename: Laurène
authors.initials: L
authors.lastname: Deconinck
authors.forename: Pierre-Yves
authors.initials: PY
authors.lastname: Hatron
authors.forename: Marc
authors.initials: M
authors.lastname: Lambert
mesh_terms: D000208:Acute Disease; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D003587:Cytomegalovirus / Q000187:drug effects / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D000998:Antiviral Agents; D014812:Vitamin K